The FDA receives more than 2 million medical device reports (MDRs) annually related to deaths, serious injuries, and malfunctions of medica devices. Especially malfunction reports represent most of the MDRs received each year.  On August 28, 2024, the FDA announced final guidance for the Voluntary Malfunction Summary Reporting (VMSR) program for manufacturers. The VMSR program simplifies the rep..

The De Novo classification is an FDA regulatory mechanism used for new medical devices that are anticipated to be Class I or Class II with low risk when there is no suitable predicate device to claim substantial equivalence. The FDA announced the final guidance on the electronic submission template for De Novo (FDA-2023-D-3788) on August 23, 2024. This guidance includes on the use of the electro..

Two new features related to product listing have been updated in the Cosmetic Direct Portal, the U.S. FDA’s electronic submission portal for MOCRA cosmetic facility registration and product listing. These updates will enhance the convenience of product management.  The two new features added to the Cosmetic Direct Portal are as follows:- Products discontinued in the market can now be marked as d..

The FDA has implemented the Voluntary Cosmetic Registration Program (VCRP) for general cosmetics, but the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) was enacted on December 29, 2022 for the safety of consumers.Under MOCRA, manufacturers who manufacture or process cosmetics distributed in the United States are required to prepare safety reports, labeling requirements, and register ..

The FDA published a revised MDSAP AUDIT APPROACH (MDSAP AU P0002.009) on August 6, 2024.The revision from MDSAP AU P0002.008 to 009 is briefly as follows. 1. Australia (TGA)As a result of changes to the Guidance for Australia (TGA) country-specific requirements, the following items have been revised or removed from the TGA requirements.1) Management - Task 5 & Task 82) Device Marketing Authoriza..

The U.S. Food and Drug Administration published a draft guidance document on March 13, 2024, of Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act. FDA intends to incorporate the updates proposed in this draft guidance into the Premarket Cybersecurity Guidance as one final guidance document after obtaining and considering public comment on these proposed select..

FDA published a Quality Management System Regulation (QMSR) final rule on February 2, 2024 to revise the current good manufacturing practice (CGMP) requirements for medical devices in the Quality System (QS) Regulation (21 CFR Part 820). FDA amends Part 820 to incorporate the QMS requirements of ISO13485 as references. Replacing the Quality System(QS) with the Quality Management System Regulatio..

The U.S. FDA was scheduled to open a platform in October to register and list cosmetics facilities required by the U.S. Cosmetics Regulatory Modernization Act (MoCRA). Therefore, the existing products sold had to be listed by December 29, 2023. However, there were many opinions from global companies and related organizations that they needed time to prepare for regulatory response. The FDA accep..

The Cosmetics Regulation Modernization Act (MoCRA) is important to the chapter VI of the Federal Food, Drugs and Cosmetics Act (FDCA) and adds new information (GMP, safety proof, critical adverse event reporting, facility registration, product registration, additional labeling marks, record keeping, etc.). It also gives the FDA the authority to order compulsory recalls. MoCRA's facility registra..

To enter the Thai beauty market, it is essential to register cosmetics with the Thai FDA. Thai cosmetics are regulated under Cosmetics Act BB.E 2558(2015). Also, Thai cosmetics are regulated by ASEAN Cosmetic Directive(ACD) under the guidelines of ASEAN Cosmetic Committee(ACC). When registering cosmetics, PIF and label are basically required. - Material safety data sheet (MFDS) - GMP or ISO of m..